Un outil pour mesurer l'impact économique de l'élimination de l'hépatite B: une étude de cas en Arabie saoudite
Summary Background No virologic cure exists for hepatitis B virus (HBV) infection, and existing therapies are designed to control viral replication. We aimed to estimate the national prevalence of HBsAg in 2017 and study the impact of an enhanced diagnosis rate and universal treatment administration on HBV-related outcomes in Saudi Arabia. Materials and methods A […]
French 
English 
Spanish 
Russian 
Arabic